Pfizer
Rady Johnson is Executive Vice President and Pfizer’s Chief Compliance, Quality and Risk Officer. He has overall responsibility for the company's global compliance program, Regulatory Quality Assurance organization, global security efforts, and Office of the Ombuds.
Since joining Pfizer in 1994, Rady has led the Regulatory Law practice group as well as the Corporate Regulatory and Healthcare Law Audit functions, established the Legal Division’s Global Products Counsel practice group, and served as Senior Vice President and Associate General Counsel for the innovative segments of Pfizer’s Worldwide Biopharmaceuticals Business. Prior to joining the company, Rady was in private practice in Washington, DC, with the law firm of Hogan & Hartson, where he was a member of their food and drug law practice. Previously, Rady was a Certified Public Accountant specializing in the healthcare and hospitality industries for Arthur Anderson. He is a graduate of the University of Richmond and the Georgetown University Law Center.
Rady was recognized by the Ethisphere Institute in 2015 as an Attorney Who Matters for his work in helping to “pioneer a corporate and industry-wide legacy of ethics and integrity.” He chairs the International Federation of Pharmaceutical Manufacturers & Associations' Ethics & Business Integrity Committee, serves on the board of directors of the Pro Bono Partnership and the Citizens Crime Commission of New York City, is an adjunct professor at the University of Connecticut School of Law, and is very active in many local charities and organizations in his hometown of Westport, CT.
This person is not in any offices
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.